CHAMPIONS ONCOLOGY, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Champions Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Champions Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending July 31, 2024 was $5.96M, a 15.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.96M -$1.13M -15.9% Jul 31, 2024 10-Q 2024-09-13
Q1 2024 $6.25M -$1.07M -14.6% Apr 30, 2024 10-Q 2024-09-13
Q4 2023 $6.54M -$1.05M -13.9% Jan 31, 2024 10-Q 2024-03-15
Q3 2023 $6.82M -$882K -11.5% Oct 31, 2023 10-Q 2023-12-13
Q2 2023 $7.09M -$879K -11% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 $7.32M -$912K -11.1% Apr 30, 2023 10-K 2024-07-19
Q4 2022 $7.59M -$828K -9.84% Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $7.7M -$563K -6.82% Oct 31, 2022 10-Q 2022-12-13
Q2 2022 $7.97M -$358K -4.3% Jul 31, 2022 10-Q 2022-09-12
Q1 2022 $8.23M -$291K -3.42% Apr 30, 2022 10-K 2023-07-24
Q4 2021 $8.42M +$3.04M +56.5% Jan 31, 2022 10-Q 2022-03-15
Q3 2021 $8.26M +$2.73M +49.5% Oct 31, 2021 10-Q 2021-12-13
Q2 2021 $8.33M +$2.66M +46.8% Jul 31, 2021 10-Q 2021-09-13
Q1 2021 $8.52M +$5.72M +205% Apr 30, 2021 10-K 2022-07-22
Q4 2020 $5.38M +$2.48M +85.4% Jan 31, 2021 10-Q 2021-03-15
Q3 2020 $5.53M +$2.52M +84% Oct 31, 2020 10-Q 2020-12-14
Q2 2020 $5.67M +$2.57M +82.8% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $2.8M +$2.8M Apr 30, 2020 10-K 2021-07-26
Q4 2019 $2.9M Jan 31, 2020 10-Q 2020-03-16
Q3 2019 $3M Oct 31, 2019 10-Q 2019-12-16
Q2 2019 $3.1M Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $0 Apr 30, 2019 10-Q 2019-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.